Taima Growth has officially become the fourth company to receive a coveted license from Spain’s Agency for Medicines and Health Products (AEMPS) to cultivate medical cannabis. This significant milestone positions Taima Growth as a key player in Spain’s burgeoning medicinal cannabis industry, opening doors for increased production and wider access to therapeutic cannabis products for…
Akanda Corp. has successfully regained compliance with Nasdaq’s periodic filing requirements, averting potential delisting. The pharmaceutical company submitted its overdue financial reports, satisfying the exchange’s stipulations and securing its position on the Nasdaq Capital Market. Akanda Corp. has met Nasdaq’s filing requirements. The company submitted its delinquent financial reports. This action prevents the potential delisting…
Pure Sunfarms has officially launched its highly anticipated Pink Kush Cured Resin Vape across Canada, offering consumers a new premium cannabis concentrate experience. New Pink Kush Cured Resin Vape now available. Features high-quality, full-spectrum cannabis. Focuses on authentic terpene profiles. Available in select Canadian provinces. A New Frontier in Cannabis Vaping The Canadian cannabis market…
FIFA’s legal team has issued a demand to a Toronto smoke shop to cease selling a bong that allegedly resembles the World Cup trophy. The move highlights FIFA’s aggressive stance on protecting its intellectual property and brand association, even in seemingly unrelated markets. Key Highlights: A Toronto-based smoke shop is under fire from FIFA lawyers….
A groundbreaking initiative has seen the first medical cannabis prescriptions issued to Ukrainian war veterans suffering from multiple sclerosis (MS). This marks a significant milestone in acknowledging and treating the complex health challenges faced by those who have served. Key Highlights: First medical cannabis prescriptions dispensed to Ukrainian war veterans with MS. Represents a new…
Exilby, a whole plant botanical cannabis treatment, has received marketing authorization in Germany, marking a significant milestone in the acceptance of cannabis-based therapies in Europe. Concurrently, the United States Food and Drug Administration (FDA) has granted Exilby a Breakthrough Therapy Designation, a signal of the drug’s potential to treat serious conditions more effectively than existing…
The drug testing industry is actively lobbying to prevent the U.S. government from rescheduling cannabis, a move that could significantly impact their business model and the reliability of current testing methods. Industry groups argue that rescheduling could lead to unreliable tests and potentially increase workplace safety risks. Key Highlights: Drug testing companies are raising concerns…
Precision farming is ushering in a new era of agricultural efficiency, with advancements in data analytics, automation, and sustainable practices set to redefine crop yields and resource management. These innovations promise significant environmental benefits and economic advantages for farmers worldwide. Key Highlights: Integration of AI and machine learning for predictive analytics. Rise of autonomous machinery…
Trulieve Cannabis Corp. is poised to make history as the first U.S. cannabis company to list its stock on the New York Stock Exchange (NYSE), a significant development for the burgeoning legal marijuana industry. Key Highlights: Trulieve will be the first U.S. cannabis company to trade on the NYSE. This listing marks a major step…
Tilray Medical Germany has officially launched ARX™, a new premium medical cannabis brand cultivated entirely within Germany. This introduction marks a significant step in expanding access to high-quality, domestically produced medical cannabis for patients across the country. Key Highlights: Launch of ARX™, a new premium medical cannabis brand. All products are cultivated in Germany, ensuring…
